MedTrace Logo

Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design

NCT00357916 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2016-04-05

No results posted yet for this study

Summary

To determine the sensitisation potential of PEP005 Topical Gel (0.01% concentration) on normal skin

To evaluate skin irritation

Conditions

  • Healthy

Interventions

DRUG

PEP005 Topical Gel (0.01% concentration)

Sponsors & Collaborators

  • Peplin

    lead INDUSTRY

Principal Investigators

  • Jonathon Dosik, MD · TKL Research, Inc.

  • Peter Welburn, PhD · Peplin Operations (Sponsor)

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2006-10-31
Completion
2006-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00357916 on ClinicalTrials.gov